Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.2500 (-0.78%) ($8.2500 - $8.2500) on Mon. Jul. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 41 | Latest Price | $8.2500(-0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(67%) ARKG(64%) IBB(56%) IWC(49%) ARKK(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.835% in a week (0% probabilities). TBT(-25%) UUP(-15%) IGOV(-8%) VXX(-6%) VIXM(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.98 | 5 Day Moving Average | $8.23(0.24%) | 10 Day Moving Average | $8.17(0.98%) | 20 Day Moving Average | $8.98(-8.13%) | To recent high | -28.2% | To recent low | 29.8% | Market Cap | $512m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |